Table 1.

Correlations between tumor budding, IL-17 expression, and clinical variables

Characteristics	Total	Tumor budding (n)			IL-17 with tumor budding (n)
		Low	High	p	Low	High	p
Sex
Male	62	29	33	0.512	35	27	0.438
Female	18	10	8		12	6
Age
≥ 48	45	23	22	0.632	29	16	0.241
< 48	35	16	19		18	17
T classification
T1-2	42	25	17	0.043*	29	13	0.049*
T3-4	38	14	24		18	20
Lymph node metastasis
N0-1	46	28	18	0.012*	33	13	0.006*
N2-3	34	11	23		14	20
Distant metastasis
No	66	36	30	0.024*	43	23	0.013*
Yes	14	3	11		4	10
Clinical stage
I-II	44	27	17	0.013*	36	8	< 0.001*
III-IV	36	12	24		11	25
Recurrence
No	48	28	20	0.036*	33	15	0.026*
Yes	32	11	21		14	18

^* P < 0.05.